Limited evidence for parent-of-origin effects in inflammatory bowel disease associated loci

PLoS One. 2012;7(9):e45287. doi: 10.1371/journal.pone.0045287. Epub 2012 Sep 27.

Abstract

Background: Genome-wide association studies of two main forms of inflammatory bowel diseases (IBD), Crohn's disease (CD) and ulcerative colitis (UC), have identified 99 susceptibility loci, but these explain only 23% of the genetic risk. Part of the 'hidden heritability' could be in transmissible genetic effects in which mRNA expression in the offspring depends on the parental origin of the allele (genomic imprinting), since children whose mothers have CD are more often affected than children with affected fathers. We analyzed parent-of-origin (POO) effects in Dutch and Indian cohorts of IBD patients.

Methods: We selected 28 genetic loci associated with both CD and UC, and tested them for POO effects in 181 Dutch IBD case-parent trios. Three susceptibility variants in NOD2 were tested in 111 CD trios and a significant finding was re-evaluated in 598 German trios. The UC-associated gene, BTNL2, reportedly imprinted, was tested in 70 Dutch UC trios. Finally, we used 62 independent Indian UC trios to test POO effects of five established Indian UC risk loci.

Results: We identified POO effects for NOD2 (L1007fs; OR = 21.0, P-value = 0.013) for CD; these results could not be replicated in an independent cohort (OR = 0.97, P-value = 0.95). A POO effect in IBD was observed for IL12B (OR = 3.2, P-value = 0.019) and PRDM1 (OR = 5.6, P-value = 0.04). In the Indian trios the IL10 locus showed a POO effect (OR = 0.2, P-value = 0.03).

Conclusions: Little is known about the effect of genomic imprinting in complex diseases such as IBD. We present limited evidence for POO effects for the tested IBD loci. POO effects explain part of the hidden heritability for complex genetic diseases but need to be investigated further.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Butyrophilins
  • Child
  • Colitis, Ulcerative / genetics*
  • Crohn Disease / genetics*
  • Female
  • Gene Expression
  • Genetic Loci*
  • Genetic Predisposition to Disease
  • Genome-Wide Association Study
  • Genomic Imprinting*
  • Humans
  • Inheritance Patterns
  • Interleukin-10 / genetics
  • Interleukin-12 Subunit p40 / genetics
  • Male
  • Membrane Glycoproteins / genetics
  • Nod2 Signaling Adaptor Protein / genetics
  • Polymorphism, Single Nucleotide*
  • Positive Regulatory Domain I-Binding Factor 1
  • Repressor Proteins / genetics
  • Risk
  • White People / genetics*

Substances

  • BTNL2 protein, human
  • Butyrophilins
  • IL10 protein, human
  • IL12B protein, human
  • Interleukin-12 Subunit p40
  • Membrane Glycoproteins
  • NOD2 protein, human
  • Nod2 Signaling Adaptor Protein
  • Repressor Proteins
  • Interleukin-10
  • PRDM1 protein, human
  • Positive Regulatory Domain I-Binding Factor 1

Grants and funding

K. Fransen was supported by a MD/PhD grant from GUIDE at University Medical Center Groningen. M. Mitrovic was supported by a PhD grant from Slovenian Research Agency (Grant No. 630-39/2012-1). U. Potocnik was supported by a grant from Slovenian Research Agency (Grant No. J3-2175). R.K. Weersma is supported by a clinical fellowship grant (90.700.281) from the Netherlands Organization for Scientific Research (NWO) and the Broad Medical Research Program of The Broad Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.